Weight Loss Is a Strong Predictor of Memory Disorder Independent of Genetic Influences.


Journal

Genes
ISSN: 2073-4425
Titre abrégé: Genes (Basel)
Pays: Switzerland
ID NLM: 101551097

Informations de publication

Date de publication:
31 07 2023
Historique:
received: 30 06 2023
revised: 26 07 2023
accepted: 27 07 2023
medline: 28 8 2023
pubmed: 26 8 2023
entrez: 26 8 2023
Statut: epublish

Résumé

Past studies identified a link between weight loss and dementia, but lacked consistent conclusions. We sought to establish this link by examining the weight change profiles before and after dementia diagnosis. Using data from the Health and Retirement Study (1996-2020), we examined 13,123 participants. We conducted a nested case-control analysis to assess differences in biennial weight change profile while controlling for BMI, longevity polygenic risk scores, and Participants with a memory disorder lost weight (-0.63%) biennially, whereas those without a diagnosis did not (+0.013%, We observe that weight loss in dementia is a physiological process independent of genetic factors associated with BMI and longevity. Pre-dementia weight loss may be an important prognostic criterion to assess a person's risk of developing a memory disorder.

Sections du résumé

BACKGROUND
Past studies identified a link between weight loss and dementia, but lacked consistent conclusions. We sought to establish this link by examining the weight change profiles before and after dementia diagnosis.
METHODS
Using data from the Health and Retirement Study (1996-2020), we examined 13,123 participants. We conducted a nested case-control analysis to assess differences in biennial weight change profile while controlling for BMI, longevity polygenic risk scores, and
RESULTS
Participants with a memory disorder lost weight (-0.63%) biennially, whereas those without a diagnosis did not (+0.013%,
CONCLUSIONS
We observe that weight loss in dementia is a physiological process independent of genetic factors associated with BMI and longevity. Pre-dementia weight loss may be an important prognostic criterion to assess a person's risk of developing a memory disorder.

Identifiants

pubmed: 37628615
pii: genes14081563
doi: 10.3390/genes14081563
pmc: PMC10454755
pii:
doi:

Substances chimiques

Apolipoproteins E 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : BLRD VA
ID : I01 BX000933
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG009740
Pays : United States
Organisme : NIA NIH HHS
ID : RC4 AG039029
Pays : United States

Références

Alzheimers Dement. 2020 Mar 10;:
pubmed: 32157811
Int J Obes (Lond). 2017 May;41(5):769-775
pubmed: 28138135
J Am Geriatr Soc. 1996 Oct;44(10):1147-52
pubmed: 8855991
J Gerontol A Biol Sci Med Sci. 2022 Oct 6;77(10):2116-2122
pubmed: 34908120
Am Fam Physician. 2014 May 1;89(9):718-22
pubmed: 24784334
Genome Med. 2020 May 18;12(1):44
pubmed: 32423490
Alzheimers Res Ther. 2015 Apr 06;7(1):18
pubmed: 25848400
Neurology. 2007 Aug 21;69(8):739-46
pubmed: 17709705
Int J Epidemiol. 2014 Apr;43(2):576-85
pubmed: 24671021
Am J Clin Nutr. 2018 Mar 1;107(3):420-426
pubmed: 29566188
Aging Clin Exp Res. 2016 Oct;28(5):805-11
pubmed: 26572157
J Clin Endocrinol Metab. 2022 Jun 16;107(7):e2710-e2716
pubmed: 35420682
J Neurol. 2004 Mar;251(3):314-20
pubmed: 15015012
Ann Neurol. 2011 Sep;70(3):418-26
pubmed: 21425187
Aging Cell. 2014 Jun;13(3):391-400
pubmed: 24628815
J Am Geriatr Soc. 2017 Mar;65(3):511-519
pubmed: 27991654
Nihon Ronen Igakkai Zasshi. 1993 Jul;30(7):602-9
pubmed: 8361078
Nat Rev Neurol. 2013 Feb;9(2):106-18
pubmed: 23296339
PLoS One. 2016 Jun 27;11(6):e0157384
pubmed: 27347878
J Gerontol A Biol Sci Med Sci. 2001 Aug;56(8):M483-8
pubmed: 11487600
Sci Rep. 2018 Oct 18;8(1):15447
pubmed: 30337578
Proc Natl Acad Sci U S A. 2010 Jan 12;107(2):786-91
pubmed: 20080753
J Am Coll Cardiol. 2014 Jul 1;63(25 Pt B):2985-3023
pubmed: 24239920
J Epidemiol. 2022 May 5;32(5):237-243
pubmed: 33390463
Arch Neurol. 2006 Sep;63(9):1312-7
pubmed: 16966511
N Engl J Med. 2010 Dec 2;363(23):2211-9
pubmed: 21121834
Alzheimer Dis Assoc Disord. 2014 Jan-Mar;28(1):36-43
pubmed: 24126214
PLoS One. 2017 Oct 4;12(10):e0185503
pubmed: 28977000
Arch Neurol. 2005 Jan;62(1):55-60
pubmed: 15642850
Int Psychogeriatr. 1992 Summer;4(1):103-18
pubmed: 1391666

Auteurs

Sunny Chen (S)

Geriatric Research, Education, and Clinical Center, Puget Sound VA Medical Center, Seattle, WA 98108, USA.
Healthcare Genetics Program, School of Nursing, Clemson University, Clemson, SC 29634, USA.

Sara M Sarasua (SM)

Healthcare Genetics Program, School of Nursing, Clemson University, Clemson, SC 29634, USA.

Nicole J Davis (NJ)

Healthcare Genetics Program, School of Nursing, Clemson University, Clemson, SC 29634, USA.

Jane M DeLuca (JM)

Healthcare Genetics Program, School of Nursing, Clemson University, Clemson, SC 29634, USA.

Stephen M Thielke (SM)

Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA 98195, USA.

Chang-En Yu (CE)

Geriatric Research, Education, and Clinical Center, Puget Sound VA Medical Center, Seattle, WA 98108, USA.
Department of Medicine, Division of Gerontology and Geriatric Medicine, University of Washington, Seattle, WA 98195, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH